Dear Sir, Please find the attachment. Regards, For MRC Agrotech Limited Authorised Signatory
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MRC Agrotech's board approved unaudited results for Q3 FY26 (Oct-Dec 2025) and 9M FY26 (Apr-Dec 2025) on 14 February 2026. Consolidated Q3 revenue from operations surged to Rs. 1,160.19 lakhs from Rs. 511.05 lakhs in Q3 FY25, more than doubling year-on-year. However, 9M FY26 consolidated revenue fell about 11% to Rs. 2,152.93 lakhs versus Rs. 2,423.83 lakhs in 9M FY25. Consolidated Q3 profit after tax (after minority interest) dropped to Rs. 17.66 lakhs from Rs. 24.46 lakhs, while EBITDA margin compressed sharply from around 6.6% to about 2.7% year-on-year. Standalone Q3 revenue nearly doubled to Rs. 1,015.97 lakhs with PAT of Rs. 15.80 lakhs versus Rs. 13.48 lakhs. The auditor issued a clean limited review report on both standalone and consolidated numbers, with no qualifications or emphasis-of-matter.
Strong Q3 topline growth is encouraging, but weaker profitability and a 9M revenue decline signal uneven business momentum and cost pressure. Shareholders should watch for margin recovery in Q4 and whether the standalone business can sustain its growth trajectory.